- Home
- MUFG vs ABT Comparison
MUFG vs ABT Comparison
Compare MUFG & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MUFG | ABT |
|---|---|---|
| Founded | 1880 | 1888 |
| Country | Japan | United States |
| Employees | 178953 | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.5B | 189.6B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | MUFG | ABT |
|---|---|---|
| Price | $16.73 | $109.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $139.38 |
| AVG Volume (30 Days) | 3.9M | ★ 6.7M |
| Earning Date | 01-01-0001 | 04-23-2026 |
| Dividend Yield | ★ 2.47% | 2.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.72 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $3.25 | $8.92 |
| Revenue Next Year | $9.79 | $7.39 |
| P/E Ratio | ★ $25.47 | $29.02 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $10.46 | $105.27 |
| 52 Week High | $20.15 | $137.49 |
Technical Indicators
Market Signals| Indicator | MUFG | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 35.95 | 42.14 |
| Support Level | $14.89 | $105.27 |
| Resistance Level | $18.90 | $113.76 |
| Average True Range (ATR) | 0.42 | 1.91 |
| MACD | -0.21 | -0.35 |
| Stochastic Oscillator | 15.71 | 21.61 |
Price Performance
Historical ComparisonAbout MUFG Mitsubishi UFJ Financial Group Inc.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets, with an 8.4% share of all domestic loans as of March 2025. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.